Novartis to probe Indian drug approval allegations

ZURICH (Reuters) - Swiss drugmaker Novartis said on Thursday it would investigate alleged drug approval irregularities in India after a parliamentary report found the country's regulator colluded with…
Read the full story: Reuters: Health News